SCHEMBL17876316

SCHEMBL17876316

c1ccc(-c2cc(-c3ccc4c(c3)-c3cc(-c5cc(-c6ccccc6)nc(-c6ccccc6)c5)ccc3CN(c3ccccc3)C4)cc(-c3ccccc3)n2)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 7/20 0.42
RAB9A P51151 5/20 0.42
NPC1 O15118 4/20 0.42
ALDH1A1 P00352 5/20 0.42
HPGD P15428 4/20 0.41
KDM4E B2RXH2 4/20 0.41
MAPK1 P28482 2/20 0.41
TDP1 Q9NUW8 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
LMNA P02545 2/20 0.39
THRB P10828 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
TYRO3 Q06418 1/20 0.38
NTRK2 Q16620 1/20 0.38
CLK4 Q9HAZ1 1/20 0.38
DYRK1B Q9Y463 1/20 0.38
NPSR1 Q6W5P4 2/20 0.38
TSHR P16473 1/20 0.38
HSD17B10 Q99714 1/20 0.38
EGFR P00533 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17876314 0.97 MAPT (0.41) MAPTRAB9ANPC1ALDH1A1HPGD
SCHEMBL17876279 0.95 MAPT (0.39) MAPTRAB9ANPC1ALDH1A1HPGD
SCHEMBL17876277 0.92 MAPT (0.37) MAPTRAB9ANPC1ALDH1A1HPGD
SCHEMBL17876264 0.92 MAPT (0.37) MAPTRAB9ANPC1ALDH1A1HPGD
SCHEMBL17876315 0.89 CYP19A1 (0.51) ALDH1A1KDM4ECYP19A1KMT2AMEN1
SCHEMBL17876287 0.87 KDM4E (0.41) MAPTRAB9ANPC1ALDH1A1HPGD
SCHEMBL17876312 0.86 NPC1 (0.49) MAPTRAB9ANPC1ALDH1A1KDM4E
SCHEMBL17876302 0.86 MAPT (0.40) MAPTRAB9ANPC1ALDH1A1HPGD
SCHEMBL17876309 0.86 MAPT (0.40) MAPTRAB9ANPC1ALDH1A1HPGD
SCHEMBL17876283 0.85 CYP19A1 (0.47) ALDH1A1KDM4ECYP19A1KMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10581000-B2 Condensed cyclic compound and organic light-emitting device including the same SAMSUNG ELECTRONICS CO., LTD. (KR) 2020-03-03 US disclosed
US-20160190482-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2016-06-30 US disclosed
US-20160190482-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2016-06-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10581000-B2 Condensed cyclic compound and organic light-emitting device including the same CRY1, CRY2, CCNE2 MAPT 2144/4885RAB9A 2843/4885NPC1 2673/4885
US-20160190482-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNE2 MAPT 2144/4885RAB9A 2843/4885NPC1 2673/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.